{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:26:32Z","timestamp":1794108392435,"version":"4.8.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["RF1AG076122"],"award-info":[{"award-number":["RF1AG076122"]}]},{"name":"NIH","award":["RF1AG068581"],"award-info":[{"award-number":["RF1AG068581"]}]},{"name":"NIH","award":["R01AG077771"],"award-info":[{"award-number":["R01AG077771"]}]},{"name":"NIH","award":["R21AG085314"],"award-info":[{"award-number":["R21AG085314"]}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2021615S"],"award-info":[{"award-number":["A2021615S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["RF1AG076122-S1"],"award-info":[{"award-number":["RF1AG076122-S1"]}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","award":["CZI 2020-222111"],"award-info":[{"award-number":["CZI 2020-222111"]}],"id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["R01AG062348"],"award-info":[{"award-number":["R01AG062348"]}]},{"name":"NIH","award":["P30AG062677"],"award-info":[{"award-number":["P30AG062677"]}]},{"name":"NIH","award":["U54NS100693"],"award-info":[{"award-number":["U54NS100693"]}]},{"DOI":"10.13039\/100016948","name":"Tau Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tauopathies represent a diverse group of neurodegenerative disorders characterized by the abnormal aggregation of the microtubule-associated protein tau. Despite extensive research, the mechanisms underlying the diversity of neuronal and glial tau pathology in different tauopathies are poorly understood. While there is a growing understanding of tauopathy-specific differences in tau isoforms and fibrillar structures, the specific composition of heterogenous tau lesions remains unknown. Here we study the protein composition of tau aggregates in four major tauopathies: Alzheimer's disease (AD), corticobasal degeneration (CBD), Pick's disease (PiD), and progressive supranuclear palsy (PSP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed an approach for in situ proximity labeling and isolation of aggregate-associated proteins using glass slides with formalin-fixed paraffin-embedded (FFPE) human postmortem brain tissue, termed Probe-dependent Proximity Profiling (ProPPr). We used ProPPr for the analysis of proteomes associated with AT8-positive cellular lesions from frontal cortices. Isolated proximity proteomes were analyzed by data-independent acquisition mass spectrometry. Co-immunofluorescence staining and quantitative data analysis for selected proteins in human brain tissue was performed to further investigate associations with diverse tau pathologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Proteomics data analysis identified numerous common and tauopathy-specific proteins associated with phospho-tau aggregates. Extensive validations of candidates through quantitative immunofluorescence imaging of distinct aggregates across disease cases demonstrate successful implementation of ProPPr for unbiased discovery of aggregate-associated proteins in in human brain tissue. Our results reveal the association of retromer complex component vacuolar protein sorting-associated protein 35 (VPS35) and lysosome-associated membrane glycoprotein 2 (LAMP2) with specific types of phospho-tau lesions in tauopathies. Furthermore, we discovered a disease-specific association of certain proteins with distinct pathological lesions, including glycogen synthase kinase alpha (GSK3\u03b1), ferritin light chain (FTL), and the neuropeptide precursor VGF. Notably, the identification of FTL-positive microglia in CBD astrocytic plaques indicate their potential role in the pathogenesis of these lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrate the suitability of the ProPPr approach in FFPE brain tissue for unbiased discovery of local proteomes that provide valuable insights into the underlying proteomic landscape of tauopathies, shedding light on the molecular mechanisms underlying tau pathology. This first comprehensive characterization of tau-associated proteomes in a range of distinct tauopathies enhances our understanding of disease heterogeneity and mechanisms, informing strategies for the development of diagnostic biomarkers and targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-025-00817-0","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:27:29Z","timestamp":1741847249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies"],"prefix":"10.1186","volume":"20","author":[{"given":"Dmytro","family":"Morderer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Wren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Maistrenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Pobitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett S.","family":"Phinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-541X","authenticated-orcid":false,"given":"Wilfried","family":"Rossoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"6 Pt 2","key":"817_CR1","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","volume":"103","author":"DG Drubin","year":"1986","unstructured":"Drubin DG, Kirschner MW. Tau protein function in living cells. J Cell Biol. 1986;103(6 Pt 2):2739\u201346.","journal-title":"J Cell Biol"},{"issue":"3","key":"817_CR2","first-page":"271","volume":"387","author":"RL Neve","year":"1986","unstructured":"Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res. 1986;387(3):271\u201380.","journal-title":"Brain Res"},{"issue":"9","key":"817_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10(9):785\u201396.","journal-title":"Lancet Neurol"},{"key":"817_CR4","doi-asserted-by":"crossref","unstructured":"Olfati N, Shoeibi A, Litvan I. Clinical Spectrum of Tauopathies. Front Neurol. 2022;13:944806.","DOI":"10.3389\/fneur.2022.944806"},{"issue":"6","key":"817_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-022-02426-3","volume":"143","author":"A Tarutani","year":"2022","unstructured":"Tarutani A, Adachi T, Akatsu H, Hashizume Y, Hasegawa K, Saito Y, et al. Ultrastructural and biochemical classification of pathogenic tau, \u03b1-synuclein and TDP-43. Acta Neuropathol. 2022;143(6):613\u201340.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"817_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"DC Chung","year":"2021","unstructured":"Chung DC, Roemer S, Petrucelli L, Dickson DW. Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener. 2021;16(1):57.","journal-title":"Mol Neurodegener"},{"key":"817_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VMY Lee","year":"2001","unstructured":"Lee VMY, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci. 2001;24:1121\u201359.","journal-title":"Annu Rev Neurosci"},{"key":"817_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J Gotz","year":"2019","unstructured":"Gotz J, Halliday G, Nisbet RM. Molecular Pathogenesis of the Tauopathies. Annu Rev Pathol. 2019;14:239\u201361.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"817_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG. Invited review: Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41(1):3\u201323.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"817_CR10","doi-asserted-by":"crossref","unstructured":"Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. Embo J. 2018;37(7):e98049.","DOI":"10.15252\/embj.201798049"},{"issue":"1","key":"817_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T Gomez-Isla","year":"1997","unstructured":"Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann Neurol. 1997;41(1):17\u201324.","journal-title":"Ann Neurol"},{"key":"817_CR12","doi-asserted-by":"crossref","unstructured":"Biel D, Brendel M, Rubinski A, Buerger K, Janowitz D, Dichgans M, et al. Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals. Alzheimers Res Ther. 2021;13(1):137.","DOI":"10.1186\/s13195-021-00880-x"},{"key":"817_CR13","doi-asserted-by":"crossref","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, et al. Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer's disease. Sci Transl Med. 2016;8(338):338ra66.","DOI":"10.1126\/scitranslmed.aaf2362"},{"issue":"5","key":"817_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","volume":"133","author":"KA Josephs","year":"2017","unstructured":"Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, et al. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol. 2017;133(5):705\u201315.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"817_CR15","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/mds.27198","volume":"32","author":"S Koga","year":"2017","unstructured":"Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker MC, Josephs KA, et al. Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Mov Disord. 2017;32(12):1772\u20139.","journal-title":"Mov Disord"},{"key":"817_CR16","doi-asserted-by":"crossref","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524):eaau5732.","DOI":"10.1126\/scitranslmed.aau5732"},{"issue":"6","key":"817_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2967\/jnumed.121.263694","volume":"63","author":"M Malpetti","year":"2022","unstructured":"Malpetti M, La Joie R, Rabinovici GD. Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials. J Nucl Med. 2022;63(6):830\u20132.","journal-title":"J Nucl Med"},{"key":"817_CR18","doi-asserted-by":"crossref","unstructured":"Marx GA, Koenigsberg DG, McKenzie AT, Kauffman J, Hanson RW, Whitney K, et al. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment. Acta Neuropathol Com. 2022;10(1):157.","DOI":"10.1186\/s40478-022-01457-x"},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, et al. Clinicopathologic and C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain. 2015;138:1370\u201381.","journal-title":"Brain"},{"issue":"16","key":"817_CR20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.wnl.0000259519.78480.c3","volume":"68","author":"R Murray","year":"2007","unstructured":"Murray R, Neumann M, Forman MS, Farmer J, Massimo L, Rice A, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology. 2007;68(16):1274\u201383.","journal-title":"Neurology"},{"issue":"3","key":"817_CR21","doi-asserted-by":"publisher","first-page":"E281","DOI":"10.1212\/WNL.0000000000200384","volume":"99","author":"JM Poos","year":"2022","unstructured":"Poos JM, MacDougall A, van den Berg E, Jiskoot LC, Papma JM, van der Ende EL, et al. Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort. Neurology. 2022;99(3):E281\u201395.","journal-title":"Neurology"},{"issue":"1","key":"817_CR22","doi-asserted-by":"publisher","first-page":"E35","DOI":"10.1212\/WNL.0000000000009734","volume":"95","author":"N Sakae","year":"2020","unstructured":"Sakae N, Santos OA, Pedraza O, Litvan I, Murray ME, Duara R, et al. Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology. 2020;95(1):E35\u201345.","journal-title":"Neurology"},{"issue":"6","key":"817_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jnen\/nlw026","volume":"75","author":"A Serrano-Pozo","year":"2016","unstructured":"Serrano-Pozo A, Qian J, Muzikansky A, Monsell SE, Montine TJ, Frosch MP, et al. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum. J Neuropath Exp Neur. 2016;75(6):516\u201326.","journal-title":"J Neuropath Exp Neur"},{"issue":"5","key":"817_CR24","doi-asserted-by":"publisher","first-page":"E506","DOI":"10.1212\/WNL.0000000000013107","volume":"98","author":"DS Smirnov","year":"2022","unstructured":"Smirnov DS, Salmon DP, Galasko D, Goodwill VS, Hansen LA, Zhao Y, et al. Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease. Neurology. 2022;98(5):E506\u201317.","journal-title":"Neurology"},{"issue":"6686","key":"817_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702\u20135.","journal-title":"Nature"},{"key":"817_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1749-6632.2000.tb06906.x","volume":"920","author":"M Hutton","year":"2000","unstructured":"Hutton M. Molecular genetics of chromosome 17 tauopathies. Ann Ny Acad Sci. 2000;920:63\u201373.","journal-title":"Ann Ny Acad Sci"},{"key":"817_CR27","doi-asserted-by":"crossref","unstructured":"Shafei R, Woollacott IOC, Mummery CJ, Bocchetta M, Guerreiro R, Bras J, et al. Two pathologically confirmed cases of novel mutations in the gene causing frontotemporal dementia. Neurobiol Aging. 2020;87:141.e15\u2013141.e20.","DOI":"10.1016\/j.neurobiolaging.2019.11.009"},{"issue":"7","key":"817_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018;14(7):399\u2013415.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"817_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00401-021-02318-y","volume":"142","author":"B Kim","year":"2021","unstructured":"Kim B, Mikytuck B, Suh E, Gibbons GS, Van Deerlin VM, Vaishnavi SN, et al. Tau immunotherapy is associated with glial responses in FTLD-tau. Acta Neuropathol. 2021;142(2):243\u201357.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"817_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1474-4422(21)00283-0","volume":"20","author":"S Koga","year":"2021","unstructured":"Koga S, Dickson DW, Wszolek Z. Neuropathology of progressive supranuclear palsy after treatment with tilavonemab. Lancet Neurol. 2021;20(10):786\u20137.","journal-title":"Lancet Neurol"},{"issue":"6","key":"817_CR31","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","volume":"146","author":"H Florian","year":"2023","unstructured":"Florian H, Wang DL, Arnold SE, Boada M, Guo Q, Jin ZY, et al. Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study. Brain. 2023;146(6):2275\u201384.","journal-title":"Brain"},{"issue":"12","key":"817_CR32","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1038\/s41591-022-02075-9","volume":"28","author":"K Horie","year":"2022","unstructured":"Horie K, Barth\u00e9lemy NR, Spina S, VandeVrede L, He YX, Paterson RW, et al. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nat Med. 2022;28(12):2547-+.","journal-title":"Nat Med."},{"key":"817_CR33","doi-asserted-by":"crossref","unstructured":"Thijssen EH, Verberk IMW, Kindermans J, Abramian A, Vanbrabant J, Ball AJ, et al. Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia. Alzh Dement-Dadm. 2022;14(1):e12285.","DOI":"10.1002\/dad2.12285"},{"key":"817_CR34","doi-asserted-by":"crossref","unstructured":"Barth\u00e9lemy NR, Bateman RJ, Hirtz C, Marin P, Becher F, Sato C, et al. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification. Alzheimers Res Ther. 2020;12(1):26.","DOI":"10.1186\/s13195-020-00596-4"},{"issue":"5","key":"817_CR35","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/alz.12452","volume":"18","author":"C Sexton","year":"2022","unstructured":"Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, et al. Current directions in tau research: Highlights from Tau 2020. Alzheimers Dement. 2022;18(5):988\u20131007.","journal-title":"Alzheimers Dement"},{"issue":"Pt 3","key":"817_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull. 2016;126(Pt 3):238\u201392.","journal-title":"Brain Res Bull"},{"issue":"13","key":"817_CR37","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","volume":"9","author":"M Goedert","year":"1990","unstructured":"Goedert M, Jakes R. Expression of Separate Isoforms of Human Tau-Protein - Correlation with the Tau-Pattern in Brain and Effects on Tubulin Polymerization. Embo J. 1990;9(13):4225\u201330.","journal-title":"Embo J"},{"issue":"7721","key":"817_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, et al. Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature. 2018;561(7721):137\u201340.","journal-title":"Nature"},{"issue":"5","key":"817_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","volume":"136","author":"B Falcon","year":"2018","unstructured":"Falcon B, Zhang W, Schweighauser M, Murzin AG, Vidal R, Garringer HJ, et al. Tau filaments from multiple cases of sporadic and inherited Alzheimer\u2019s disease adopt a common fold. Acta Neuropathol. 2018;136(5):699\u2013708.","journal-title":"Acta Neuropathol"},{"issue":"7752","key":"817_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568(7752):420\u20133.","journal-title":"Nature"},{"issue":"7662","key":"817_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature. 2017;547(7662):185\u201390.","journal-title":"Nature"},{"issue":"7880","key":"817_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi Y, Zhang W, Yang Y, Murzin AG, Falcon B, Kotecha A, et al. Structure-based classification of tauopathies. Nature. 2021;598(7880):359\u201363.","journal-title":"Nature"},{"issue":"7802","key":"817_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","volume":"580","author":"W Zhang","year":"2020","unstructured":"Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580(7802):283\u20137.","journal-title":"Nature"},{"issue":"25","key":"817_CR44","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1016\/j.cell.2021.11.029","volume":"184","author":"T Arakhamia","year":"2021","unstructured":"Arakhamia T, Lee CE, Carlomagno Y, Kumar M, Duong DM, Wesseling H, et al. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains. Cell. 2021;184(25):6207\u201310.","journal-title":"Cell"},{"issue":"4","key":"817_CR45","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Sharma AM, et al. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. Neuron. 2016;92(4):796\u2013812.","journal-title":"Neuron"},{"issue":"6","key":"817_CR46","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 2014;82(6):1271\u201388.","journal-title":"Neuron"},{"key":"817_CR47","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/brain\/awab091","volume":"144","author":"A Tarutani","year":"2021","unstructured":"Tarutani A, Miyata H, Nonaka T, Hasegawa K, Yoshida M, Saito Y, et al. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification. Brain. 2021;144:2333\u201348.","journal-title":"Brain"},{"issue":"1","key":"817_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00401-021-02301-7","volume":"142","author":"J Vaquer-Alicea","year":"2021","unstructured":"Vaquer-Alicea J, Diamond MI, Joachimiak LA. Tau strains shape disease. Acta Neuropathol. 2021;142(1):57\u201371.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"817_CR49","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research. Alzheimers & Dementia. 2021;17(9):1554\u201374.","journal-title":"Alzheimers & Dementia"},{"issue":"3","key":"817_CR50","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"D Dickson","year":"2011","unstructured":"Dickson D, Kouri N, Murray M, Josephs K. Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau). J Mol Neurosci. 2011;45(3):384\u20139.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"817_CR51","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.24559","volume":"79","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, et al. Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol. 2016;79(2):272\u201387.","journal-title":"Ann Neurol"},{"issue":"4","key":"817_CR52","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG, et al. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis progressive supranuclear palsy. Acta Neuropathol. 2022;144(4):603\u201314.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"817_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","volume":"17","author":"DW Dickson","year":"2007","unstructured":"Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: Pathology and genetics. Brain Pathol. 2007;17(1):74\u201382.","journal-title":"Brain Pathol"},{"issue":"1\u20132","key":"817_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0304-3940(92)90227-X","volume":"143","author":"M Nishimura","year":"1992","unstructured":"Nishimura M, Namba Y, Ikeda K, Oda M. Glial Fibrillary Tangles with Straight Tubules in the Brains of Patients with Progressive Supranuclear Palsy. Neurosci Lett. 1992;143(1\u20132):35\u20138.","journal-title":"Neurosci Lett"},{"issue":"10","key":"817_CR55","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","volume":"17","author":"M Stamelou","year":"2021","unstructured":"Stamelou M, Respondek G, Giagkou N, Whitwell JL, Kovacs GG, H\u00f6glinger GU. Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol. 2021;17(10):601\u201320.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"817_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","volume":"7","author":"N Kouri","year":"2011","unstructured":"Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol. 2011;7(5):263\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"21","key":"817_CR57","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","volume":"34","author":"AS Rose","year":"2018","unstructured":"Rose AS, Bradley AR, Valasatava Y, Duarte JM, Prlic A, Rose PW. NGL viewer: web-based molecular graphics for large complexes. Bioinformatics. 2018;34(21):3755\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"817_CR58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-022-00572-6","volume":"17","author":"T Kavanagh","year":"2022","unstructured":"Kavanagh T, Halder A, Drummond E. Tau interactome and RNA binding proteins in neurodegenerative diseases. Mol Neurodegener. 2022;17(1):66.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"817_CR59","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, et al. Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain. Brain. 2020;143(9):2803\u201317.","journal-title":"Brain"},{"key":"817_CR60","doi-asserted-by":"crossref","unstructured":"Schweighauser M, Murzin AG, Macdonald J, Lavenir I, Crowther RA, Scheres SHW, et al. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau. Acta Neuropathol Com. 2023;11(1):160.","DOI":"10.1186\/s40478-023-01658-y"},{"issue":"1","key":"817_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-023-00601-y","volume":"18","author":"K Wenger","year":"2023","unstructured":"Wenger K, Viode A, Schlaffner CN, van Zalm P, Cheng L, Dellovade T, et al. Common mouse models of tauopathy reflect early but not late human disease. Mol Neurodegener. 2023;18(1):10.","journal-title":"Mol Neurodegener"},{"issue":"21","key":"817_CR62","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1002\/pmic.201200279","volume":"12","author":"N Hashimoto","year":"2012","unstructured":"Hashimoto N, Hamamura K, Kotani N, Furukawa K, Kaneko K, Honke K, et al. Proteomic analysis of ganglioside-associated membrane molecules: substantial basis for molecular clustering. Proteomics. 2012;12(21):3154\u201363.","journal-title":"Proteomics"},{"issue":"21","key":"817_CR63","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1073\/pnas.0710346105","volume":"105","author":"N Kotani","year":"2008","unstructured":"Kotani N, Gu J, Isaji T, Udaka K, Taniguchi N, Honke K. Biochemical visualization of cell surface molecular clustering in living cells. Proc Natl Acad Sci U S A. 2008;105(21):7405\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"817_CR64","doi-asserted-by":"publisher","first-page":"14434","DOI":"10.1074\/jbc.M113.529578","volume":"289","author":"XW Li","year":"2014","unstructured":"Li XW, Rees JS, Xue P, Zhang H, Hamaia SW, Sanderson B, et al. New insights into the DT40 B cell receptor cluster using a proteomic proximity labeling assay. J Biol Chem. 2014;289(21):14434\u201347.","journal-title":"J Biol Chem"},{"key":"817_CR65","doi-asserted-by":"publisher","first-page":"19271","DOI":"10.1002\/0471140864.ps1927s80","volume":"80","author":"JS Rees","year":"2015","unstructured":"Rees JS, Li XW, Perrett S, Lilley KS, Jackson AP. Selective Proteomic Proximity Labeling Assay Using Tyramide (SPPLAT): A Quantitative Method for the Proteomic Analysis of Localized Membrane-Bound Protein Clusters. Curr Protoc Protein Sci. 2015;80:19271\u2013192718.","journal-title":"Curr Protoc Protein Sci."},{"issue":"2","key":"817_CR66","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nmeth.4533","volume":"15","author":"DZ Bar","year":"2018","unstructured":"Bar DZ, Atkatsh K, Tavarez U, Erdos MR, Gruenbaum Y, Collins FS. Biotinylation by antibody recognition-a method for proximity labeling. Nat Methods. 2018;15(2):127\u201333.","journal-title":"Nat Methods"},{"issue":"1","key":"817_CR67","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1038\/s41467-023-44015-2","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Fu Y, Peng L, Ogawa Y, Ding X, Rasband A, et al. Immunoproximity biotinylation reveals the axon initial segment proteome. Nat Commun. 2023;14(1):8201.","journal-title":"Nat Commun"},{"key":"817_CR68","doi-asserted-by":"crossref","unstructured":"Killinger BA, Marshall LL, Chatterjee D, Chu Y, Bras J, Guerreiro R, et al. In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain. Proc Natl Acad Sci U S A. 2022;119(5):e2114405119.","DOI":"10.1073\/pnas.2114405119"},{"issue":"4","key":"817_CR69","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/jnc.15796","volume":"165","author":"RAW Radford","year":"2023","unstructured":"Radford RAW, Rayner SL, Szwaja P, Morsch M, Cheng F, Zhu T, et al. Identification of phosphorylated tau protein interactors in progressive supranuclear palsy (PSP) reveals networks involved in protein degradation, stress response, cytoskeletal dynamics, metabolic processes, and neurotransmission. J Neurochem. 2023;165(4):563\u201386.","journal-title":"J Neurochem"},{"issue":"5","key":"817_CR70","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jalz.2018.12.013","volume":"15","author":"OA Santos","year":"2019","unstructured":"Santos OA, Pedraza O, Lucas JA, Duara R, Greig-Custo MT, Al-Shaikh FSH, et al. Ethnoracial differences in Alzheimer\u2019s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort. Alzheimers & Dementia. 2019;15(5):635\u201343.","journal-title":"Alzheimers & Dementia"},{"issue":"1","key":"817_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8(1):1\u201313.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"817_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 2012;123(1):1\u201311.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"817_CR73","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jalz.2015.07.492","volume":"12","author":"TJ Montine","year":"2016","unstructured":"Montine TJ, Monsell SE, Beach TG, Bigio EH, Bu Y, Cairns NJ, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(2):164\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"817_CR74","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers & Dementia. 2011;7(3):263\u20139.","journal-title":"Alzheimers & Dementia"},{"issue":"1","key":"817_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VMY, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114(1):5\u201322.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"817_CR76","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"JJ Hauw","year":"1994","unstructured":"Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, et al. Preliminary Ninds Neuropathologic Criteria for Steele-Richardson-Olszewski Syndrome (Progressive Supranuclear Palsy). Neurology. 1994;44(11):2015\u20139.","journal-title":"Neurology"},{"issue":"5","key":"817_CR77","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496\u2013503.","journal-title":"Neurology"},{"issue":"6","key":"817_CR78","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755\u201366.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"817_CR79","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, R\u00fcb U, Yamaguchi H, Del Tredici K, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropath Exp Neur. 2002;61(3):282\u201393.","journal-title":"J Neuropath Exp Neur"},{"issue":"14","key":"817_CR80","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","volume":"78","author":"V Deramecourt","year":"2012","unstructured":"Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 2012;78(14):1043\u201350.","journal-title":"Neurology"},{"issue":"5","key":"817_CR81","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bpa.12041","volume":"23","author":"LJL Craggs","year":"2013","unstructured":"Craggs LJL, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson A, Andersen O, Viitanen M, et al. Quantitative Vascular Pathology and Phenotyping Familial and Sporadic Cerebral Small Vessel Diseases. Brain Pathol. 2013;23(5):547\u201357.","journal-title":"Brain Pathol"},{"issue":"12","key":"817_CR82","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium. Neurology. 2005;65(12):1863\u201372.","journal-title":"Neurology"},{"issue":"7","key":"817_CR83","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW. Alzheimer disease with amygdala Lewy bodies: A distinct form of \u03b1-synucleinopathy. J Neuropath Exp Neur. 2006;65(7):685\u201397.","journal-title":"J Neuropath Exp Neur"},{"key":"817_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-030-51140-1_13","volume":"1281","author":"M Neumann","year":"2021","unstructured":"Neumann M, Lee EB, Mackenzie IR. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance. Adv Exp Med Biol. 2021;1281:201\u201317.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"817_CR85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, et al. Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009;117(2):137\u201349.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"817_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","volume":"117","author":"IRA Mackenzie","year":"2009","unstructured":"Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117(1):15\u20138.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"817_CR87","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"5","key":"817_CR88","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.24493","volume":"78","author":"KA Josephs","year":"2015","unstructured":"Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Liesinger AM, et al. TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features. Ann Neurol. 2015;78(5):697\u2013709.","journal-title":"Ann Neurol"},{"issue":"4","key":"817_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"817_CR90","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18(4):351\u20137.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"817_CR91","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"key":"817_CR92","unstructured":"Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997;18(4 Suppl):S1\u20132."},{"key":"817_CR93","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/brain\/awr053","volume":"134","author":"PT Nelson","year":"2011","unstructured":"Nelson PT, Schmitt FA, Lin YS, Abner EL, Jicha GA, Patel E, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain. 2011;134:1506\u201318.","journal-title":"Brain"},{"issue":"3","key":"817_CR94","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/alz.12749","volume":"19","author":"CM Moloney","year":"2023","unstructured":"Moloney CM, Labuzan SA, Crook JE, Siddiqui H, Castanedes-Casey M, Lachner C, et al. Phosphorylated tau sites that are elevated in Alzheimer\u2019s disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the brain. Alzheimers & Dementia. 2023;19(3):1029\u201340.","journal-title":"Alzheimers & Dementia"},{"issue":"12","key":"817_CR95","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier F, Brunner AD, Frank M, Ha A, Bludau I, Voytik E, et al. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat Methods. 2020;17(12):1229\u201336.","journal-title":"Nat Methods"},{"issue":"7381","key":"817_CR96","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature10719","volume":"481","author":"S Jager","year":"2011","unstructured":"Jager S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, et al. Global landscape of HIV-human protein complexes. Nature. 2011;481(7381):365\u201370.","journal-title":"Nature"},{"issue":"3","key":"817_CR97","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nprot.2017.147","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang X, Smits AH, van Tilburg GB, Ovaa H, Huber W, Vermeulen M. Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat Protoc. 2018;13(3):530\u201350.","journal-title":"Nat Protoc"},{"issue":"5","key":"817_CR98","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"GC Yu","year":"2012","unstructured":"Yu GC, Wang LG, Han YY, He QY. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"2","key":"817_CR99","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2019","unstructured":"Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2019;18(2):623\u201332.","journal-title":"J Proteome Res"},{"key":"817_CR100","doi-asserted-by":"crossref","unstructured":"Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation. Plos One. 2010;5(11):e13984.","DOI":"10.1371\/journal.pone.0013984"},{"issue":"11","key":"817_CR101","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"817_CR102","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis: Springer-Verlag New York; 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"issue":"5","key":"817_CR103","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/acel.12501","volume":"15","author":"S Ayyadevara","year":"2016","unstructured":"Ayyadevara S, Balasubramaniam M, Parcon PA, Barger SW, Griffin WST, Alla R, et al. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer\u2019s hippocampus from normal controls. Aging Cell. 2016;15(5):924\u201339.","journal-title":"Aging Cell"},{"issue":"11","key":"817_CR104","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1074\/mcp.M115.050724","volume":"14","author":"CG Gunawardana","year":"2015","unstructured":"Gunawardana CG, Mehrabian M, Wang X, Mueller I, Lubambo IB, Jonkman JE, et al. The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome. Mol Cell Proteomics. 2015;14(11):3000\u201314.","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"817_CR105","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","volume":"29","author":"YC Hsieh","year":"2019","unstructured":"Hsieh YC, Guo C, Yalamanchili HK, Abreha M, Al-Ouran R, Li Y, et al. Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer\u2019s Disease. Cell Rep. 2019;29(2):301-16e10.","journal-title":"Cell Rep."},{"issue":"3","key":"817_CR106","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3233\/JAD-150298","volume":"48","author":"S Meier","year":"2015","unstructured":"Meier S, Bell M, Lyons DN, Ingram A, Chen J, Gensel JC, et al. Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer\u2019s Disease Brain. J Alzheimers Dis. 2015;48(3):687\u2013702.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"817_CR107","doi-asserted-by":"publisher","first-page":"16238","DOI":"10.1038\/s41598-019-52543-5","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang X, Williams D, Muller I, Lemieux M, Dukart R, Maia IBL, et al. Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L Tau to non-muscle myosins. Sci Rep. 2019;9(1):16238.","journal-title":"Sci Rep"},{"issue":"4","key":"817_CR108","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","volume":"185","author":"TE Tracy","year":"2022","unstructured":"Tracy TE, Madero-Perez J, Swaney DL, Chang TS, Moritz M, Konrad C, et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. 2022;185(4):712-28e14.","journal-title":"Cell."},{"issue":"18","key":"817_CR109","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease. Jama-J Am Med Assoc. 2010;303(18):1832\u201340.","journal-title":"Jama-J Am Med Assoc"},{"key":"817_CR110","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-016-0292-9","volume":"4","author":"A Piras","year":"2016","unstructured":"Piras A, Collin L, Gruninger F, Graff C, Ronnback A. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol Commun. 2016;4:22.","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 20","key":"817_CR111","first-page":"4693","volume":"125","author":"MN Seaman","year":"2012","unstructured":"Seaman MN. The retromer complex - endosomal protein recycling and beyond. J Cell Sci. 2012;125(Pt 20):4693\u2013702.","journal-title":"J Cell Sci"},{"key":"817_CR112","doi-asserted-by":"publisher","first-page":"105768","DOI":"10.1016\/j.nbd.2022.105768","volume":"170","author":"ET Williams","year":"2022","unstructured":"Williams ET, Chen X, Otero PA, Moore DJ. Understanding the contributions of VPS35 and the retromer in neurodegenerative disease. Neurobiol Dis. 2022;170: 105768.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"817_CR113","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89(1):168\u201375.","journal-title":"Am J Hum Genet"},{"issue":"5\u20136","key":"817_CR114","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","volume":"27","author":"EL Eskelinen","year":"2006","unstructured":"Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med. 2006;27(5\u20136):495\u2013502.","journal-title":"Mol Aspects Med"},{"issue":"2","key":"817_CR115","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.emboj.7601511","volume":"26","author":"KK Huynh","year":"2007","unstructured":"Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. Embo J. 2007;26(2):313\u201324.","journal-title":"Embo J"},{"issue":"2","key":"817_CR116","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1582-4934.2009.00973.x","volume":"15","author":"A Schneede","year":"2011","unstructured":"Schneede A, Schmidt CK, Holtta-Vuori M, Heeren J, Willenborg M, Blanz J, et al. Role for LAMP-2 in endosomal cholesterol transport. J Cell Mol Med. 2011;15(2):280\u201395.","journal-title":"J Cell Mol Med"},{"issue":"6938","key":"817_CR117","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VMY, Klein PS. GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides. Nature. 2003;423(6938):435\u20139.","journal-title":"Nature"},{"issue":"32","key":"817_CR118","doi-asserted-by":"publisher","first-page":"23331","DOI":"10.1074\/jbc.M113.463984","volume":"288","author":"A Cavallini","year":"2013","unstructured":"Cavallini A, Brewerton S, Bell A, Sargent S, Glover S, Hardy C, et al. An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease. J Biol Chem. 2013;288(32):23331\u201347.","journal-title":"J Biol Chem"},{"key":"817_CR119","doi-asserted-by":"crossref","unstructured":"Quinn JP, Kandigian SE, Trombetta BA, Arnold SE, Carlyle BC. VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases. Brain Commun. 2021;3(4):fcab261.","DOI":"10.1093\/braincomms\/fcab261"},{"issue":"4","key":"817_CR120","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ng571","volume":"28","author":"AR Curtis","year":"2001","unstructured":"Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28(4):350\u20134.","journal-title":"Nat Genet"},{"issue":"4","key":"817_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jnen\/64.4.280","volume":"64","author":"M Mancuso","year":"2005","unstructured":"Mancuso M, Davidzon G, Kurlan RM, Tawil R, Bonilla E, Di Mauro S, et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol. 2005;64(4):280\u201394.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"817_CR122","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/jnen\/63.4.363","volume":"63","author":"R Vidal","year":"2004","unstructured":"Vidal R, Ghetti B, Takao M, Brefel-Courbon C, Uro-Coste E, Glazier BS, et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol. 2004;63(4):363\u201380.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"817_CR123","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217(2):459\u201372.","journal-title":"J Cell Biol"},{"issue":"2","key":"817_CR124","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1365-2990.2012.01272.x","volume":"39","author":"GG Kovacs","year":"2013","unstructured":"Kovacs GG, Rozemuller AJM, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, et al. Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium. Neuropath Appl Neuro. 2013;39(2):166\u201378.","journal-title":"Neuropath Appl Neuro"},{"issue":"4","key":"817_CR125","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1750-3639.1999.tb00549.x","volume":"9","author":"T Komori","year":"1999","unstructured":"Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick\u2019s disease. Brain Pathol. 1999;9(4):663\u201379.","journal-title":"Brain Pathol"},{"issue":"2","key":"817_CR126","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1021\/pr100812d","volume":"10","author":"NJ Nirmalan","year":"2011","unstructured":"Nirmalan NJ, Hughes C, Peng J, McKenna T, Langridge J, Cairns DA, et al. Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations. J Proteome Res. 2011;10(2):896\u2013906.","journal-title":"J Proteome Res"},{"issue":"1","key":"817_CR127","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40478-020-01079-1","volume":"8","author":"AM Wojtas","year":"2020","unstructured":"Wojtas AM, Carlomagno Y, Sens JP, Kang SS, Jensen TD, Kurti A, et al. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Acta Neuropathol Commun. 2020;8(1):210.","journal-title":"Acta Neuropathol Commun"},{"issue":"19","key":"817_CR128","doi-asserted-by":"publisher","first-page":"7917","DOI":"10.1074\/jbc.RA119.007527","volume":"294","author":"A Yu","year":"2019","unstructured":"Yu A, Fox SG, Cavallini A, Kerridge C, O\u2019Neill MJ, Wolak J, et al. Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network. J Biol Chem. 2019;294(19):7917\u201330.","journal-title":"J Biol Chem"},{"issue":"2","key":"817_CR129","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.242720499","volume":"100","author":"F Dou","year":"2003","unstructured":"Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, et al. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A. 2003;100(2):721\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"817_CR130","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddh083","volume":"13","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet. 2004;13(7):703\u201314.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"817_CR131","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest. 2007;117(3):648\u201358.","journal-title":"J Clin Invest"},{"issue":"47","key":"817_CR132","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1021\/bi2009147","volume":"50","author":"KR Patterson","year":"2011","unstructured":"Patterson KR, Ward SM, Combs B, Voss K, Kanaan NM, Morfini G, et al. Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport. Biochemistry. 2011;50(47):10300\u201310.","journal-title":"Biochemistry"},{"issue":"28","key":"817_CR133","doi-asserted-by":"publisher","first-page":"9676","DOI":"10.1074\/jbc.RA120.013478","volume":"295","author":"E Nachman","year":"2020","unstructured":"Nachman E, Wentink AS, Madiona K, Bousset L, Katsinelos T, Allinson K, et al. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species. J Biol Chem. 2020;295(28):9676\u201390.","journal-title":"J Biol Chem"},{"issue":"1","key":"817_CR134","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41467-023-36058-2","volume":"14","author":"I Saha","year":"2023","unstructured":"Saha I, Yuste-Checa P, Da Silva PM, Guo Q, Korner R, Holthusen H, et al. The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system. Nat Commun. 2023;14(1):560.","journal-title":"Nat Commun"},{"issue":"1","key":"817_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40478-021-01159-w","volume":"9","author":"M Criado-Marrero","year":"2021","unstructured":"Criado-Marrero M, Gebru NT, Blazier DM, Gould LA, Baker JD, Beaulieu-Abdelahad D, et al. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice. Acta Neuropathol Commun. 2021;9(1):65.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"817_CR136","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/s41467-021-25060-1","volume":"12","author":"P Yuste-Checa","year":"2021","unstructured":"Yuste-Checa P, Trinkaus VA, Riera-Tur I, Imamoglu R, Schaller TF, Wang H, et al. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun. 2021;12(1):4863.","journal-title":"Nat Commun"},{"issue":"10","key":"817_CR137","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1172\/JCI69003","volume":"123","author":"LJ Blair","year":"2013","unstructured":"Blair LJ, Nordhues BA, Hill SE, Scaglione KM, O\u2019Leary JC 3rd, Fontaine SN, et al. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. J Clin Invest. 2013;123(10):4158\u201369.","journal-title":"J Clin Invest"},{"issue":"22","key":"817_CR138","doi-asserted-by":"publisher","first-page":"16798","DOI":"10.1074\/jbc.M110.113753","volume":"285","author":"UK Jinwal","year":"2010","unstructured":"Jinwal UK, O\u2019Leary JC 3rd, Borysov SI, Jones JR, Li Q, Koren J 3rd, et al. Hsc70 rapidly engages tau after microtubule destabilization. J Biol Chem. 2010;285(22):16798\u2013805.","journal-title":"J Biol Chem"},{"issue":"2","key":"817_CR139","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-2009-1049","volume":"17","author":"E Tortosa","year":"2009","unstructured":"Tortosa E, Santa-Maria I, Moreno F, Lim F, Perez M, Avila J. Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein. J Alzheimers Dis. 2009;17(2):319\u201325.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"817_CR140","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1080\/15548627.2023.2181614","volume":"19","author":"SH Kim","year":"2023","unstructured":"Kim SH, Cho YS, Kim Y, Park J, Yoo SM, Gwak J, et al. Endolysosomal impairment by binding of amyloid beta or MAPT\/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease. Autophagy. 2023;19(8):2318\u201337.","journal-title":"Autophagy"},{"issue":"3","key":"817_CR141","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/nan.12500","volume":"45","author":"HDC Bain","year":"2019","unstructured":"Bain HDC, Davidson YS, Robinson AC, Ryan S, Rollinson S, Richardson A, et al. The role of lysosomes and autophagosomes in frontotemporal lobar degeneration. Neuropathol Appl Neurobiol. 2019;45(3):244\u201361.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"817_CR142","doi-asserted-by":"crossref","unstructured":"Hamano T, Enomoto S, Shirafuji N, Ikawa M, Yamamura O, Yen SH, et al. Autophagy and Tau Protein. Int J Mol Sci. 2021;22(14):7475.","DOI":"10.3390\/ijms22147475"},{"issue":"22","key":"817_CR143","doi-asserted-by":"publisher","first-page":"e2315690121","DOI":"10.1073\/pnas.2315690121","volume":"121","author":"K Rose","year":"2024","unstructured":"Rose K, Jepson T, Shukla S, Maya-Romero A, Kampmann M, Xu K, et al. Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes. Proc Natl Acad Sci U S A. 2024;121(22): e2315690121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"817_CR144","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.apsb.2022.01.008","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xu C, Sun J, Shen HM, Wang J, Yang C. Impairment of the autophagy-lysosomal pathway in Alzheimer\u2019s diseases: Pathogenic mechanisms and therapeutic potential. Acta Pharm Sin B. 2022;12(3):1019\u201340.","journal-title":"Acta Pharm Sin B"},{"issue":"20","key":"817_CR145","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1016\/j.molcel.2021.07.038","volume":"81","author":"L Jiang","year":"2021","unstructured":"Jiang L, Lin W, Zhang C, Ash PEA, Verma M, Kwan J, et al. Interaction of tau with HNRNPA2B1 and N(6)-methyladenosine RNA mediates the progression of tauopathy. Mol Cell. 2021;81(20):4209-27 e12.","journal-title":"Mol Cell."},{"issue":"5","key":"817_CR146","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00401-016-1663-9","volume":"133","author":"P Wang","year":"2017","unstructured":"Wang P, Joberty G, Buist A, Vanoosthuyse A, Stancu IC, Vasconcelos B, et al. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo. Acta Neuropathol. 2017;133(5):731\u201349.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"817_CR147","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ana.20667","volume":"58","author":"SA Small","year":"2005","unstructured":"Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, et al. Model-guided microarray implicates the retromer complex in Alzheimer\u2019s disease. Ann Neurol. 2005;58(6):909\u201319.","journal-title":"Ann Neurol"},{"issue":"1","key":"817_CR148","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ana.25752","volume":"88","author":"ME Curtis","year":"2020","unstructured":"Curtis ME, Yu D, Pratico D. Dysregulation of the Retromer Complex System in Down Syndrome. Ann Neurol. 2020;88(1):137\u201347.","journal-title":"Ann Neurol"},{"issue":"13","key":"817_CR149","doi-asserted-by":"publisher","first-page":"110182","DOI":"10.1016\/j.celrep.2021.110182","volume":"37","author":"S Simoes","year":"2021","unstructured":"Simoes S, Guo J, Buitrago L, Qureshi YH, Feng X, Kothiya M, et al. Alzheimer\u2019s vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling. Cell Rep. 2021;37(13): 110182.","journal-title":"Cell Rep"},{"issue":"1","key":"817_CR150","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1038\/s41467-023-38719-8","volume":"14","author":"JL Daly","year":"2023","unstructured":"Daly JL, Danson CM, Lewis PA, Zhao L, Riccardo S, Di Filippo L, et al. Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health. Nat Commun. 2023;14(1):3086.","journal-title":"Nat Commun"},{"issue":"9","key":"817_CR151","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1080\/15548627.2020.1821545","volume":"17","author":"JM Carosi","year":"2021","unstructured":"Carosi JM, Hein LK, van den Hurk M, Adams R, Milky B, Singh S, et al. Retromer regulates the lysosomal clearance of MAPT\/tau. Autophagy. 2021;17(9):2217\u201337.","journal-title":"Autophagy"},{"issue":"12","key":"817_CR152","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1073\/pnas.1814909116","volume":"116","author":"X Chen","year":"2019","unstructured":"Chen X, Kordich JK, Williams ET, Levine N, Cole-Strauss A, Marshall L, et al. Parkinson\u2019s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci U S A. 2019;116(12):5765\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"817_CR153","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/s41419-020-03228-9","volume":"11","author":"CC Chiu","year":"2020","unstructured":"Chiu CC, Weng YH, Huang YZ, Chen RS, Liu YC, Yeh TH, et al. (D620N) VPS35 causes the impairment of Wnt\/beta-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death Dis. 2020;11(11):1018.","journal-title":"Cell Death Dis"},{"issue":"1","key":"817_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.61.1.1","volume":"61","author":"L Gao","year":"2020","unstructured":"Gao L, Xiao H, Ai LQ, Chen C, Lin S, Zhou Y, et al. Vps35 Deficiency Impairs Cdk5\/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells. Invest Ophthalmol Vis Sci. 2020;61(1):1.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"817_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0350-4","volume":"15","author":"JG Li","year":"2020","unstructured":"Li JG, Chiu J, Ramanjulu M, Blass BE, Pratico D. A pharmacological chaperone improves memory by reducing Abeta and tau neuropathology in a mouse model with plaques and tangles. Mol Neurodegener. 2020;15(1):1.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"817_CR156","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.stemcr.2018.01.031","volume":"10","author":"JE Young","year":"2018","unstructured":"Young JE, Fong LK, Frankowski H, Petsko GA, Small SA, Goldstein LSB. Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer\u2019s Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports. 2018;10(3):1046\u201358.","journal-title":"Stem Cell Reports"},{"issue":"10","key":"817_CR157","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.cell.2024.03.015","volume":"187","author":"C Parra Bravo","year":"2024","unstructured":"Parra Bravo C, Giani AM, Madero-Perez J, Zhao Z, Wan Y, Samelson AJ, et al. Human iPSC 4R tauopathy model uncovers modifiers of tau propagation. Cell. 2024;187(10):2446-64 e22.","journal-title":"Cell."},{"issue":"Pt 6","key":"817_CR158","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1242\/jcs.109.6.1537","volume":"109","author":"U Wagner","year":"1996","unstructured":"Wagner U, Utton M, Gallo JM, Miller CC. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci. 1996;109(Pt 6):1537\u201343.","journal-title":"J Cell Sci"},{"issue":"2","key":"817_CR159","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/acschemneuro.5b00262","volume":"7","author":"CJ Dunning","year":"2016","unstructured":"Dunning CJ, McGauran G, Will\u00e9n K, Gouras GK, O\u2019Connell DJ, Linse S. Direct High Affinity Interaction between A\u03b242 and GSK3\u03b1 Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer\u2019s Disease? Acs Chem Neurosci. 2016;7(2):161\u201370.","journal-title":"Acs Chem Neurosci."},{"key":"817_CR160","doi-asserted-by":"crossref","unstructured":"Behnke J, Cheedalla A, Bhatt V, Bhat M, Teng S, Palmieri A, et al. Neuropeptide VGF Promotes Maturation of Hippocampal Dendrites That Is Reduced by Single Nucleotide Polymorphisms. Int J Mol Sci. 2017;18(3):612.","DOI":"10.3390\/ijms18030612"},{"issue":"48","key":"817_CR161","doi-asserted-by":"publisher","first-page":"34638","DOI":"10.1074\/jbc.M113.510917","volume":"288","author":"YC Chen","year":"2013","unstructured":"Chen YC, Pristera A, Ayub M, Swanwick RS, Karu K, Hamada Y, et al. Identification of a receptor for neuropeptide VGF and its role in neuropathic pain. J Biol Chem. 2013;288(48):34638\u201346.","journal-title":"J Biol Chem"},{"issue":"28","key":"817_CR162","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1523\/JNEUROSCI.0584-15.2015","volume":"35","author":"WJ Lin","year":"2015","unstructured":"Lin WJ, Jiang C, Sadahiro M, Bozdagi O, Vulchanova L, Alberini CM, et al. VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism. J Neurosci. 2015;35(28):10343\u201356.","journal-title":"J Neurosci"},{"key":"817_CR163","doi-asserted-by":"crossref","unstructured":"Duits FH, Brinkmalm G, Teunissen CE, Brinkmalm A, Scheltens P, Van der Flier WM, et al. Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease. Alzheimers Res Ther. 2018;10:5.","DOI":"10.1186\/s13195-017-0335-x"},{"issue":"8","key":"817_CR164","doi-asserted-by":"publisher","first-page":"e0135365","DOI":"10.1371\/journal.pone.0135365","volume":"10","author":"RC Hendrickson","year":"2015","unstructured":"Hendrickson RC, Lee AY, Song Q, Liaw A, Wiener M, Paweletz CP, et al. High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer\u2019s Disease in Human Cerebrospinal Fluid. PLoS ONE. 2015;10(8): e0135365.","journal-title":"PLoS ONE"},{"issue":"2","key":"817_CR165","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1021\/pr501076j","volume":"14","author":"M Holtta","year":"2015","unstructured":"Holtta M, Minthon L, Hansson O, Holmen-Larsson J, Pike I, Ward M, et al. An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. J Proteome Res. 2015;14(2):654\u201363.","journal-title":"J Proteome Res"},{"key":"817_CR166","doi-asserted-by":"crossref","unstructured":"Llano DA, Bundela S, Mudar RA, Devanarayan V, Init AsDN. A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression. Plos One. 2017;12(8):e0182098.","DOI":"10.1371\/journal.pone.0182098"},{"issue":"4","key":"817_CR167","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/WAD.0000000000000328","volume":"33","author":"DA Llano","year":"2019","unstructured":"Llano DA, Devanarayan P, Devanarayan V, Initia ADN. VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to AD. Alz Dis Assoc Dis. 2019;33(4):307\u201314.","journal-title":"Alz Dis Assoc Dis"},{"issue":"1","key":"817_CR168","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.1038\/s41598-020-64461-y","volume":"10","author":"SA Park","year":"2020","unstructured":"Park SA, Jung JM, Park JS, Lee JH, Park B, Kim HJ, et al. SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer\u2019s disease. Sci Rep. 2020;10(1):7423.","journal-title":"Sci Rep"},{"key":"817_CR169","doi-asserted-by":"crossref","unstructured":"Remnest\u00e5l J, \u00d6ijerstedt L, Ullgren A, Olofsson J, Bergstr\u00f6m S, Kultima K, et al. Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers. Transl Neurodegener. 2020;9(1):27.","DOI":"10.1186\/s40035-020-00198-y"},{"issue":"2","key":"817_CR170","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.expneurol.2005.08.002","volume":"196","author":"U Ruetschi","year":"2005","unstructured":"Ruetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, et al. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp Neurol. 2005;196(2):273\u201381.","journal-title":"Exp Neurol"},{"issue":"4","key":"817_CR171","doi-asserted-by":"publisher","first-page":"e1800105","DOI":"10.1002\/prca.201800105","volume":"13","author":"G Sathe","year":"2019","unstructured":"Sathe G, Na CH, Renuse S, Madugundu AK, Albert M, Moghekar A, et al. Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer\u2019s Disease. Proteomics Clin Appl. 2019;13(4): e1800105.","journal-title":"Proteomics Clin Appl"},{"issue":"4","key":"817_CR172","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/acn3.745","volume":"6","author":"EL van der Ende","year":"2019","unstructured":"van der Ende EL, Meeter LH, Stingl C, van Rooij JGJ, Stoop MP, Nijholt DAT, et al. Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics. Ann Clin Transl Neurol. 2019;6(4):698\u2013707.","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"817_CR173","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1469-7580.2010.01309.x","volume":"217","author":"C Cocco","year":"2010","unstructured":"Cocco C, D\u2019Amato F, Noli B, Ledda A, Brancia C, Bongioanni P, et al. Distribution of VGF peptides in the human cortex and their selective changes in Parkinson\u2019s and Alzheimer\u2019s diseases. J Anat. 2010;217(6):683\u201393.","journal-title":"J Anat"},{"issue":"6","key":"817_CR174","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang XS, Li YX, Chen PC, Yu KW, Dey KK, et al. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer\u2019s Disease Progression. Neuron. 2020;105(6):975-+","journal-title":"Neuron."},{"issue":"3","key":"817_CR175","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12031-018-1124-0","volume":"68","author":"C Jiang","year":"2019","unstructured":"Jiang C, Lin WJ, Salton SR. Role of a VGF\/BDNF\/TrkB Autoregulatory Feedback Loop in Rapid-Acting Antidepressant Efficacy. J Mol Neurosci. 2019;68(3):504\u20139.","journal-title":"J Mol Neurosci"},{"key":"817_CR176","doi-asserted-by":"crossref","unstructured":"Lin WJ, Zhao Y, Li Z, Zheng SY, Zou JL, Warren NA, et al. An increase in VGF expression through a rapid, transcription-independent, autofeedback mechanism improves cognitive function. Transl Psychiat. 2021;11(1):383.","DOI":"10.1038\/s41398-021-01489-2"},{"key":"817_CR177","doi-asserted-by":"crossref","unstructured":"Beckmann ND, Lin WJ, Wang MH, Cohain AT, Charney AW, Wang P, et al. Multiscale causal networks identify VGF as a key regulator of Alzheimer's disease.\u00a0Nat\u00a0Commun. 2020;11(1):3942.","DOI":"10.1038\/s41467-020-17405-z"},{"key":"817_CR178","doi-asserted-by":"crossref","unstructured":"Tasaki S, Gaiteri C, Mostafavi S, De Jager PL, Bennett DA. The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia. Front Neurosci-Switz. 2018;12:699.","DOI":"10.3389\/fnins.2018.00699"},{"issue":"2","key":"817_CR179","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ana.26676","volume":"94","author":"L Yu","year":"2023","unstructured":"Yu L, Petyuk VA, Lopes KD, Tasaki S, Menon V, Wang YL, et al. Associations of VGF with Neuropathologies and Cognitive Health in Older Adults. Ann Neurol. 2023;94(2):232\u201344.","journal-title":"Ann Neurol"},{"key":"817_CR180","doi-asserted-by":"crossref","unstructured":"El Gaamouch F, Audrain M, Lin WJ, Beckmann N, Jiang C, Hariharan S, et al. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.\u00a0Mol\u00a0Neurodegener. 2020;15(1):4.","DOI":"10.1186\/s13024-020-0357-x"},{"issue":"4","key":"817_CR181","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jnr.490370405","volume":"37","author":"JR Connor","year":"1994","unstructured":"Connor JR, Boeshore KL, Benkovic SA, Menzies SL. Isoforms of Ferritin Have a Specific Cellular-Distribution in the Brain. J Neurosci Res. 1994;37(4):461\u20135.","journal-title":"J Neurosci Res"},{"issue":"6","key":"817_CR182","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00401-011-0888-x","volume":"122","author":"AS Ebrahim","year":"2011","unstructured":"Ebrahim AS, Kulathingal J, Murray ME, Casey-Castanedes M, Dickson DW, Yen SH, et al. A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. 2011;122(6):727\u201336.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"817_CR183","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/glia.20678","volume":"56","author":"KO Lopes","year":"2008","unstructured":"Lopes KO, Sparks DL, Streit WJ. Microglial dystrophy in the aged and Alzheimer\u2019s disease brain is associated with ferritin immunoreactivity. Glia. 2008;56(10):1048\u201360.","journal-title":"Glia"},{"key":"817_CR184","doi-asserted-by":"crossref","unstructured":"Kenkhuis B, Somarakis A, de Haan L, Dzyubachyk O, IJsselsteijn ME, de Miranda NFCC, et al. Iron loading is a prominent feature of activated microglia in Alzheimer's disease patients. Acta Neuropathol Com. 2021;9(1):27.","DOI":"10.1186\/s40478-021-01126-5"},{"issue":"12","key":"817_CR185","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/glia.23510","volume":"66","author":"WJ Streit","year":"2018","unstructured":"Streit WJ, Braak H, Del Tredici K, Leyh J, Lier J, Khoshbouei H, et al. Microglial activation occurs late during preclinical Alzheimer\u2019s disease. Glia. 2018;66(12):2550\u201362.","journal-title":"Glia"},{"key":"817_CR186","doi-asserted-by":"crossref","unstructured":"Falkon KF, Danford L, Gutierrez Kuri E, Esquinca-Moreno P, Pena Seneriz YL, Smith S, et al. Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms. Alzheimers Dement. 2025;21:e14418.","DOI":"10.1002\/alz.14418"},{"issue":"11","key":"817_CR187","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","volume":"80","author":"RN Taddei","year":"2023","unstructured":"Taddei RN, Perbet R, de Mate Gerando A, Wiedmer AE, Sanchez-Mico M, Connors Stewart T, et al. Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease. JAMA Neurol. 2023;80(11):1209\u201321.","journal-title":"JAMA Neurol."},{"issue":"8","key":"817_CR188","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.celrep.2018.07.072","volume":"24","author":"J Brelstaff","year":"2018","unstructured":"Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG. Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia. Cell Rep. 2018;24(8):1939-48e4.","journal-title":"Cell Rep."},{"key":"817_CR189","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2020.12.003","volume":"99","author":"RK Shahidehpour","year":"2021","unstructured":"Shahidehpour RK, Higdon RE, Crawford NG, Neltner JH, Ighodaro ET, Patel E, et al. Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain. Neurobiol Aging. 2021;99:19\u201327.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"817_CR190","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1021\/acs.jproteome.0c00137","volume":"19","author":"J Sinsky","year":"2020","unstructured":"Sinsky J, Majerova P, Kovac A, Kotlyar M, Jurisica I, Hanes J. Physiological Tau Interactome in Brain and Its Link to Tauopathies. J Proteome Res. 2020;19(6):2429\u201342.","journal-title":"J Proteome Res"},{"key":"817_CR191","doi-asserted-by":"crossref","unstructured":"Maziuk BF, Apicco DJ, Cruz AL, Jiang L, Ash PEA, da Rocha EL, et al. RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathol Com. 2018;6:71.","DOI":"10.1186\/s40478-018-0574-5"},{"issue":"15","key":"817_CR192","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1074\/jbc.M115.641902","volume":"291","author":"C Liu","year":"2016","unstructured":"Liu C, Song XM, Nisbet R, G\u00f6tz J. Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease. J Biol Chem. 2016;291(15):8173\u201388.","journal-title":"J Biol Chem"},{"issue":"7","key":"817_CR193","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1021\/jasms.3c00099","volume":"34","author":"GP Pujari","year":"2023","unstructured":"Pujari GP, Mangalaparthi KK, Madden BJ, Bhat FA, Charlesworth MC, French AJ, et al. A High-Throughput Workflow for FFPE Tissue Proteomics. J Am Soc Mass Spectr. 2023;34(7):1225\u20139.","journal-title":"J Am Soc Mass Spectr"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00817-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00817-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:50:51Z","timestamp":1741848651000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00817-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00817-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.25.585597","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All donors had provided written informed consent for the use of autopsy material and of clinical and genetic information for research purposes. Brain tissue was obtained postmortem following IRB review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}